| Name | Title | Contact Details |
|---|
The new and innovated concept of DeliverIt Pharmacy came from our 20 years of experience. We have seen it all, the frustrations and hassles customers have to go through just to get their prescription. At DeliverIt Pharmacy we strive to keep the balance of affordable and convenience for our customers while performing proficiently and efficiently. We conveniently offer a variety of ways for you to get your prescription such as delivery, drive-thru, and walk-in pickup so there`s no frustrating long-lines to wait in. This will allow you to spend more time with your family, or return to your busy schedule of work or school! We offer compounding, which allows us to work with your physician to customized your prescription to your individual needs. We care for your love one`s well-being just as much as you do! Whether it`s your children, parents, or pets! We offer a variety of methods to make it easier for you to get them to comply with their medication
Heron Therapeutics is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action. The Company's lead product, SUSTOL™ (formerly APF530), is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting. Heron Therapeutics received a Complete Response Letter to its SUSTOL New Drug Application (NDA) and is targeting a resubmission of the NDA to the U.S. Food and Drug Administration during the fourth quarter of 2014. Heron Therapeutics' core Biochronomer technology, on which SUSTOL and its other products are based, consists of bioerodible polymers designed to release drugs over a defined period of time. The Company has completed over 100 in vivo and in vitro studies demonstrating that its Biochronomer technology is potentially applicable to a range of therapeutic areas, including prevention of nausea and vomiting, pain management, control of inflammation and treatment of ophthalmic diseases. Heron Therapeutics has also completed comprehensive animal and human toxicology studies that have established that its Biochronomer polymers are generally well tolerated. Furthermore, the Company's Biochronomer technology can be designed to deliver drugs over periods varying from days to several months. In addition to its lead drug candidate SUSTOL, Heron Therapeutics has a pipeline of other product candidates that use the Biochronomer technology.
Sirtris Pharmaceuticals is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AxelaCare Health Solutions is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
J&S Studies, Inc. is a Bryan, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.